| Page 5 | Aplastic Anemia and MDS International Foundation

2018 March for Marrow Walk Miami

Join us for a morning of fun, remembrance, and awareness at our 3rd annual March for Marrow Walk Miami in memory of Jennifer Zighelboim. This year we move to a new walk location - Historic Virginia Key Beach Park! Festivities include a food truck and live music, as well as a day of fun connecting with fellow patients and families affected by

Event Date: 
Sat, 05/12/2018 -
10:00am to 1:00pm
Community Event Type: 

Concurrent treatment of aplastic anemia/Paroxysmal Nocturnal Hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience

Author(s): 
Griffin M, Kulasekararaj A, Gandhi S, Munir T, Richards S, Arnold L, Benson-Quarm N, Copeland N, Duggins I, Riley K, Hillmen P, Marsh J, Hill A
Primary Author: 
Griffin M
Journal Title: 
Haematologica
Original Publication Date: 
Mar 2018

Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes

Author(s): 
Daver N, Boddu P, Garcia-Manero G, Yadav SS, Sharma P, Allison J, Kantarjian H
Primary Author: 
Daver N
Journal Title: 
Leukemia
Original Publication Date: 
Feb 2018

Immune checkpoint inhibitors, as single-agent therapy, have shown modest clinical efficacy in the treatment of acute myeloid leukemia (AML) and

Bone Marrow Diseases: 

Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study

Author(s): 
Troy JD, de Castro CM, Pupa MR, Samsa GP, Abernethy AP, LeBlanc TW
Primary Author: 
Troy JD
Journal Title: 
J Natl Compr Canc Netw
Original Publication Date: 
Mar 2018

PMID: 29523665

Bone Marrow Diseases: